3Navari R M. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting-two new agents[J]. J Support Oncol, 2003,1(2):89- 103.
4Cubeddu L X. Serotonin mechanisms in chemotherapy induced emesis in cancer patients[J]. Oncology, 1996, 53(Suppl 1) : 18- 25.
5Hesketh P J, Van Belle S, Aapro M, et ah Differential involvement of neurotransmitters through the time course of cisplatin induced emesis as revealed by therapy with specific receptor antagonists [J] . Eur J Cancer, 2003,39(8) : 1074--1080.
6Blower P B. Comparative pharmacology of 5-HT3 receptor an tagonist[J]. J Hos formula,1994, 29(5):84--86.
7Andnew P L R, Bhandan P, Draw H, et al. Are all 5-HT3 receptor antagonist the same? [J]. Eur J Cancer, 1992,28(5) :82--86.
8Longfield V. Compatibility and stability of 5-HT3 receptor antagonists:a pharmacology review [J]. Oncol Nurs Forum, 2002, 29(20):1469-- 1482.
9Del Giglio A, Soares H P, Caparroz C, et al. Granisteron is equivalent to ondansteron for prophylaxis of chemotherapy-induced nausea and vomiting[J]. Cancer, 2000, 89(6) : 2301 -- 2308.
10Jordan K, Hinke A, Grothey A, et al. Granisetron versus tropisetron for prophylaxis of acute chemotherapy induced emesis: A pooled analysis[J]. Support Care Cancer, 2005,13(1) :26--31.
